| Date | Title | Description |
| 18.09.2024 | CS MEDICA A/S: Expanding Horizons in the US and Asia | CS MEDICA A/S is on a mission. The Danish MedTech company is making waves in the healthcare sector, targeting both the US and Asian markets. With a focus on bioactive cannabidiol (CBD) treatments, CS MEDICA is carving out a niche in pain ma... |
| 18.09.2024 | CS MEDICA A/S Announces Strategic Partnership with Scan MedPartners to Expand Reach into the US Market | CS MEDICA A/S Announces Strategic Partnership with Scan MedPartners to Expand Reach into the US Market
Wed, Sep 18, 2024 09:37 CET Report this content
CS MEDICA A/S targets the US market for its regulated treatments with bioactive cannabidi... |
| 17.09.2024 | CS MEDICA Announces Approval of CANNASEN® Pain Patch in Malaysia and Trademark Registration in Thailand | CS MEDICA Announces Approval of CANNASEN® Pain Patch in Malaysia and Trademark Registration in Thailand
Tue, Sep 17, 2024 11:18 CET Report this content
Overcoming Regulatory Challenges, CS MEDICA Expands its Footprint in Asia with Latest Ap... |
| 02.09.2024 | CANNORDIC India Ltd., a CS MEDICA Subsidiary, Signs Letter of Intent with the Pharmaceutical Company Zuventus Healthcare to Launch CANNASEN® in India | CANNORDIC India Ltd., a CS MEDICA Subsidiary, Signs Letter of Intent with the Pharmaceutical Company Zuventus Healthcare to Launch CANNASEN® in India
Mon, Sep 02, 2024 11:14 CET Report this content
The Partnership Projects Up to €15 Million... |
| 02.09.2024 | CEO Letter: Updates on BSI and Last Months' Activities | CEO Letter: Updates on BSI and Last Months' Activities
Mon, Sep 02, 2024 16:47 CET Report this content
I am happy to share our four key CS MEDICA updates, demonstrating our commitment to resilience and market expansion.
ISO 13485 Certificat... |
| 21.08.2024 | CS MEDICA Achieves MDR Classification, Setting New Standards in Substance-Based Medical Devices | CS MEDICA Achieves MDR Classification, Setting New Standards in Substance-Based Medical Devices
Wed, Aug 21, 2024 16:28 CET Report this content
Leading Healthcare Innovation with Stringent Compliance
CS MEDICA, a pioneer in MedTech speciali... |
| 20.08.2024 | CS MEDICA Pioneers CBD-Infused Medical Devices in Jordan with Confirmed Classification | CS MEDICA Pioneers CBD-Infused Medical Devices in Jordan with Confirmed Classification
Tue, Aug 20, 2024 10:25 CET Report this content
Newly classified products set to boost market presence with an initial order of 100,000 units in Jordan a... |
| 19.08.2024 | CS MEDICA Q3 2023/2024: Growth Through Strategic Regulatory and Market Adaptations | CS MEDICA Q3 2023/2024: Growth Through Strategic Regulatory and Market Adaptations
Mon, Aug 19, 2024 08:55 CET Report this content
Navigating Complex Markets with Innovations Leads to a 400% Increase in Revenue Year-to-Date and an Expansive... |
| 16.08.2024 | CS MEDICA Q3 2023/2024 Results: Strong Revenue Growth of 400% Despite Production Delays | CS MEDICA Q3 2023/2024 Results: Strong Revenue Growth of 400% Despite Production Delays
Fri, Aug 16, 2024 08:30 CET Report this content
Revenue Grew Over 400% Year-to-Date, and Order Intake Hit mDKK 49.3, Fueled by Strategic Partnerships an... |
| 07.08.2024 | CS MEDICA's CANNORDIC Names Pharma Avanti as Preferred Partner in Brazil | CS MEDICA's CANNORDIC Names Pharma Avanti as Preferred Partner in Brazil
Wed, Aug 07, 2024 10:30 CET Report this content
Pioneering Access to Innovative Pain Relief and CBD Solutions and Gateway to South America
CS MEDICA A/S announces a ne... |
| 02.08.2024 | CS MEDICA's Subsidiary, CANNORDIC, Signs Distributor Partnership with PHARMALINK | CS MEDICA's Subsidiary, CANNORDIC, Signs Distributor Partnership with PHARMALINK
Fri, Aug 02, 2024 15:25 CET Report this content
Expanding Access to Innovative Healthcare Solutions in the UAE
CS MEDICA A/S, a pioneering MedTech company spec... |
| 01.08.2024 | Press Release: CS MEDICA's View of the Evolving European CBD Market | Press Release: CS MEDICA's View of the Evolving European CBD Market
Thu, Aug 01, 2024 11:07 CET Report this content
Strategic Investments in Compliance and Evidence-Based Treatments to Drive Growth
CS MEDICA, a Danish MedTech pioneer focusi... |
| 31.07.2024 | CS MEDICA A/S: Minutes of Extraordinary General Meeting | CS MEDICA A/S: Minutes of Extraordinary General Meeting
Wed, Jul 31, 2024 11:10 CET Report this content
CS MEDICA Approves Key Proposals at Extraordinary General Meeting
CS MEDICA (”CS MEDICA” or “The Company”) is pleased to announce the su... |
| 27.07.2024 | CS MEDICA's Innovative Leap: A New Dawn for Psoriasis Treatment | In the world of dermatology, innovation is a lifeline. CS MEDICA, a Danish MedTech company, is making waves with its latest achievement: an "Intention To Grant" for a European patent concerning its CANNASEN® Psoriasis Gel. This ge... |
| 26.07.2024 | CS MEDICA Leverages Strategic Partnerships for CANNASEN® Brand Launch in APAC and MENA | CS MEDICA Leverages Strategic Partnerships for CANNASEN® Brand Launch in APAC and MENA
Fri, Jul 26, 2024 09:22 CET Report this content
Launching 36,000 Units to Test Market Fit and Accelerate Market Penetration at a value of €419,000
CS MED... |
| 26.07.2024 | CS MEDICA A/S Evaluates Pre-IPO Share Distribution for CANNORDIC Stock Spin-off | CS MEDICA A/S Evaluates Pre-IPO Share Distribution for CANNORDIC Stock Spin-off
Fri, Jul 26, 2024 14:56 CET Report this content
CS MEDICA Aims to Strengthen Shareholder Bonds with Pre-IPO Share Distribution for CANNORDIC in Germany
CS MEDIC... |
| 24.07.2024 | CS MEDICA Receives "Intention To Grant" for European Patent Application Concerning CANNASEN® Psoriasis Gel, Reinforcing Leadership in CBD-infused Dermatological Innovations | CS MEDICA Receives "Intention To Grant" for European Patent Application Concerning CANNASEN® Psoriasis Gel, Reinforcing Leadership in CBD-infused Dermatological Innovations
Wed, Jul 24, 2024 10:23 CET Report this content
Innovativ... |
| 19.07.2024 | CS MEDICA A/S Secures Repurchase Orders from Key European Partners | CS MEDICA A/S Secures Repurchase Orders from Key European Partners
Fri, Jul 19, 2024 09:45 CET Report this content
CANNORDIC Continues Momentum with Recurring Orders of 45.000 Units from European Healthcare Leaders
CS MEDICA, a pioneering M... |
| 15.07.2024 | CS MEDICA A/S: Notice of Extraordinary General Meeting | CS MEDICA A/S: Notice of Extraordinary General Meeting
Mon, Jul 15, 2024 15:35 CET Report this content
The shareholders of CS MEDICA A/S ("CS MEDICA" or the "Company") are hereby notified of an Extraordinary General Meet... |
| 15.07.2024 | CS MEDICA Announces Strategic Partnerships to Enhance Funding | CS MEDICA Announces Strategic Partnerships to Enhance Funding
Mon, Jul 15, 2024 15:38 CET Report this content
Securing New Capital and Strengthening Shareholder Relations Through Strategic Collaborations
CS MEDICA, a pioneering MedTech comp... |
| 01.07.2024 | CS MEDICA Stock Now Also Traded on XETRA | CS MEDICA Stock Now Also Traded on XETRA
Mon, Jul 01, 2024 16:45 CET Report this content
Enhanced Liquidity and Trading Opportunities for Shareholders
CS MEDICA (“CS MEDICA” or “The Company”), a MedTech pioneer specializing in pain manageme... |
| 28.06.2024 | CS MEDICA A/S: Minutes of Extraordinary General Meeting | CS MEDICA A/S: Minutes of Extraordinary General Meeting
Fri, Jun 28, 2024 12:20 CET Report this content
Today on June 28, 2024, in Copenhagen - CS MEDICA A/S (”CS MEDICA” or “The Company”) held an extraordinary general meeting at which the ... |
| 28.06.2024 | CS MEDICA: CEO Insights on Achievements and Future Plans | CS MEDICA: CEO Insights on Achievements and Future Plans
Fri, Jun 28, 2024 14:32 CET Report this content
Q&A on German IPO, Structural Enhancements, and Growth Strategies.
Q&As from the CEO
I want to reflect on our recent achievemen... |
| 17.06.2024 | CS MEDICA Group Completes Product Registration of CANNASEN® CBD-Infused Medical Devices in Israel | CS MEDICA Group Completes Product Registration of CANNASEN® CBD-Infused Medical Devices in Israel
Mon, Jun 17, 2024 15:35 CET Report this content
Strategic Milestone Achieved as CANNORDIC, a CS MEDICA Subsidiary, Navigates Regulatory Challe... |
| 12.06.2024 | CS MEDICA Announces Strategic Partnership with OneMed | CS MEDICA Announces Strategic Partnership with OneMed
Wed, Jun 12, 2024 15:09 CET Report this content
CS MEDICA Signs with OneMed for Enhanced Distribution and Marketing in Denmark
CS MEDICA is happy to announce a new strategic partnership ... |
| 11.06.2024 | Strategic Expansion through Innovation and Collaboration | Strategic Expansion through Innovation and Collaboration
Tue, Jun 11, 2024 08:00 CET Report this content
CS MEDICA A/S Announces Strategic Letter of Intent with GP Europe Holding B.V.
CS MEDICA A/S ("CS MEDICA"), a first mover in ... |
| 10.06.2024 | CS MEDICA A/S: Notice of Extraordinary General Meeting | CS MEDICA A/S: Notice of Extraordinary General Meeting
Mon, Jun 10, 2024 15:00 CET Report this content
The shareholders of CS MEDICA A/S ("CS MEDICA" or the "Company") are hereby notified of an Extraordinary General Meet... |
| 10.06.2024 | CS MEDICA Plans Stock Spin-Off and Listing of CANNORDIC | CS MEDICA Plans Stock Spin-Off and Listing of CANNORDIC
Mon, Jun 10, 2024 14:00 CET Report this content
CS MEDICA A/S, a pioneering MedTech company specializing in innovative substance-based medical devices containing bioactive CBD, today a... |
| 28.05.2024 | CS MEDICA receives 2 MDKK to support its short-term financial obligations. | CS MEDICA receives 2 MDKK to support its short-term financial obligations.
Tue, May 28, 2024 17:14 CET Report this content
CS MEDICA A/S (“CS MEDICA” or “the Company”) announces it has received a loan of 2 million DKK to support its short a... |
| 17.05.2024 | CS MEDICA A/S announces financial results for the first half of the financial year 2023/24 | CS MEDICA A/S announces financial results for the first half of the financial year 2023/24
Fri, May 17, 2024 15:43 CET Report this content
CS MEDICA ("CS MEDICA" or the "Company") publishes its H1 report for the period J... |
| 07.05.2024 | CS MEDICA Aligns Financial Priorities: Transition to Calendar Year 2024 Postponed | CS MEDICA Aligns Financial Priorities: Transition to Calendar Year 2024 Postponed
Tue, May 07, 2024 15:37 CET Report this content
CS MEDICA A/S Optimizes Financial Planning with Rescheduled Year-End
CS MEDICA, a MedTech innovator in cannabi... |
| 30.04.2024 | CS MEDICA A/S Enters New Partnership with Award-Winning OTC Company Holding a Strong Position in the Chronic Pain Segment in Germany | CS MEDICA A/S Enters New Partnership with Award-Winning OTC Company Holding a Strong Position in the Chronic Pain Segment in Germany
Tue, Apr 30, 2024 13:32 CET Report this content
CS MEDICA A/S Accelerates European Expansion by Launching 1... |
| 25.04.2024 | Correction: CS MEDICA A/S: CEO, Lone Henriksen, buys shares in the Company | Correction: CS MEDICA A/S: CEO, Lone Henriksen, buys shares in the Company
Thu, Apr 25, 2024 11:29 CET Report this content
CS MEDICA A/S posted earlier today a press release informing that that CEO, Lone Henriksen has acquired in total of 7... |
| 25.04.2024 | CS MEDICA A/S: CEO, Lone Henriksen, buys shares in the Company | CS MEDICA A/S: CEO, Lone Henriksen, buys shares in the Company
Thu, Apr 25, 2024 11:03 CET Report this content
CS MEDICA A/S announces today that CEO, Lone Henriksen has acquired in total of 7.610 shares in CS MEDICA at an average price of ... |
| 22.04.2024 | CS MEDICA Advances Global Reach with 180˚ Drug Store Alliance, Powered by Pull Market Strategy. | CS MEDICA Advances Global Reach with 180˚ Drug Store Alliance, Powered by Pull Market Strategy.
Mon, Apr 22, 2024 15:26 CET Report this content
Strategic Alliance Catalyzes Market Penetration with a Potential of 440,000 Units in the First Y... |
| 04.04.2024 | CS MEDICA A/S Breaks Through Asian Market Barrier with Approval of Protective Nasal Gel in Malaysia | CS MEDICA A/S Breaks Through Asian Market Barrier with Approval of Protective Nasal Gel in Malaysia
Thu, Apr 04, 2024 14:01 CET Report this content
CS MEDICA is now set to launch its CANNASEN® Protective Nasal Gel for sale in the first Asia... |
| 03.04.2024 | CS MEDICA Update: Rescheduled Q4 2023 Presentation | CS MEDICA Update: Rescheduled Q4 2023 Presentation
Wed, Apr 03, 2024 16:48 CET Report this content
CS MEDICA announces a new date for the Q4 2023 Report Presentation event: 12 April at 11 AM CET.
CS MEDICA announces a new date for our live-... |
| 02.04.2024 | Correction:CS MEDICA A/S: Publication of 2023 Q report | Correction:CS MEDICA A/S: Publication of 2023 Q report
Tue, Apr 02, 2024 16:01 CET Report this content
CS MEDICA A/S posted March the 29th 2024 a press release, releasing its quarterly report for for the period October – December 2023. The ... |
| 29.03.2024 | CS MEDICA A/S: Release of 2023 Q report, for the period October – December 2023, including an invitation to a live-streamed conference call on 5st April, at 11 AM CET. | CS MEDICA A/S: Release of 2023 Q report, for the period October – December 2023, including an invitation to a live-streamed conference call on 5st April, at 11 AM CET.
Fri, Mar 29, 2024 08:00 CET Report this content
CS MEDICA (”CS MEDICA” o... |
| 29.02.2024 | CS MEDICA A/S: Minutes of the General Assembly | CS MEDICA A/S: Minutes of the General Assembly
Thu, Feb 29, 2024 16:36 CET Report this content
Today on February 29, 2024, in Copenhagen - CS MEDICA A/S (”CS MEDICA” or the ”Company”) held its annual general meeting (“AGM”) at which the fol... |
| 28.02.2024 | Letter from the CEO: CS MEDICA's 2024 Progress Report | Letter from the CEO: CS MEDICA's 2024 Progress Report
Wed, Feb 28, 2024 15:40 CET Report this content
CS MEDICA Provides Insights on Continued Growth and Strategic Health.
As a follow-up to our Annual Report, we're still navigating through ... |
| 20.02.2024 | CS MEDICA A/S Partners with New Distributor to Launch CANNASEN® into Jordan | CS MEDICA A/S Partners with New Distributor to Launch CANNASEN® into Jordan
Tue, Feb 20, 2024 08:02 CET Report this content
CS MEDICA A/S and Nabih Nabulsi Drugstores disclose a strategic alliance to distribute CANNASEN® treatments with CBD... |
| 15.02.2024 | Correction:CS MEDICA A/S: Publication of annual report 2022/2023 | Correction:CS MEDICA A/S: Publication of annual report 2022/2023
Thu, Feb 15, 2024 12:47 CET Report this content
CS MEDICA A/S posted yesterday a press release releasing its annual report for 2022/2023. The press release was erroneously mis... |
| 14.02.2024 | CS MEDICA A/S: Notice of Shareholders’ Annual General Meeting | CS MEDICA A/S: Notice of Shareholders’ Annual General Meeting
Wed, Feb 14, 2024 18:52 CET Report this content
The shareholders of CS MEDICA A/S (”CS MEDICA” or the ”Company”) are hereby notified of the Annual General Meeting that will be he... |
| 14.02.2024 | CS MEDICA A/S: Publication of Annual Report 2022/2023 | CS MEDICA A/S: Publication of Annual Report 2022/2023
Wed, Feb 14, 2024 18:49 CET Report this content
CS MEDICA releases its Annual Report 2022/2023 today. Highlights will be presented at a live-streamed conference call on Wednesday the 21 ... |
| 02.02.2024 | CS MEDICA A/S Achieves New Milestone with Patent on their Wound Care Treatment. | CS MEDICA A/S Achieves New Milestone with Patent on their Wound Care Treatment.
Fri, Feb 02, 2024 14:38 CET Report this content
CS MEDICA received its third-issued patent on its "Wound Gel," offering an advanced healing process fo... |
| 26.01.2024 | CS MEDICA Breaks New Ground in Australia with Registration of CANNASEN® Pain Patch and Launch of its Cosmetic Products. | CS MEDICA Breaks New Ground in Australia with Registration of CANNASEN® Pain Patch and Launch of its Cosmetic Products.
Fri, Jan 26, 2024 15:23 CET Report this content
CS MEDICA marks a significant milestone by introducing its medical devic... |
| 23.01.2024 | Danske Bank Extends CS MEDICA's Credit Line | Danske Bank Extends CS MEDICA's Credit Line
Tue, Jan 23, 2024 16:00 CET Report this content
Danske Bank has extended its 1,2 million DKK credit line to CS MEDICA.
CS MEDICA, a global MedTech company specializing in CBD and pain management, ... |
| 27.12.2023 | CS MEDICA A/S Announces FDA authorization for commercialization for Eight Products in the U.S. Market | CS MEDICA A/S Announces FDA authorization for commercialization for Eight Products in the U.S. Market
Wed, Dec 27, 2023 13:32 CET Report this content
The authorization marks a significant step in the company's growth journey, resulting in t... |
| 14.12.2023 | CS MEDICA A/S presents the CEO Letter of December 2023 | CS MEDICA A/S presents the CEO Letter of December 2023
Thu, Dec 14, 2023 08:30 CET Report this content
Yet another year is coming to an end; it has undoubtedly been hectic and challenging, but we are proud of our progress as a smaller MedTe... |
| 29.11.2023 | CS MEDICA postpones its Annual Report to February 24, 2024 and the Annual General Meeting to February 29, 2024 | CS MEDICA postpones its Annual Report to February 24, 2024 and the Annual General Meeting to February 29, 2024
Wed, Nov 29, 2023 11:52 CET Report this content
CS MEDICA has chosen to delay the release of its Annual Report to Wednesday, Febr... |
| 22.11.2023 | CS MEDICA A/S: Release of 2022/2023 Q4 report, for the period July – September 2023, including an invitation to a live-streamed conference call on 5st December, at 11 AM CET. | CS MEDICA A/S: Release of 2022/2023 Q4 report, for the period July – September 2023, including an invitation to a live-streamed conference call on 5st December, at 11 AM CET.
Wed, Nov 22, 2023 16:42 CET Report this content
CS MEDICA (”CS ME... |
| 17.11.2023 | CS MEDICA defers the Q4 2022/2023 quarterly report until Wednesday 22. November 2023 | CS MEDICA defers the Q4 2022/2023 quarterly report until Wednesday 22. November 2023
Fri, Nov 17, 2023 17:17 CET Report this content
CS MEDICA is postponing the Year-end-Report Q4 2022/2023 until Wednesday 22. November 2023.
CS MEDICA A/S (... |
| 31.10.2023 | CS MEDICA A/S Achieves Milestone with Patent on Nasal Protect Gel | CS MEDICA A/S Achieves Milestone with Patent on Nasal Protect Gel
Tue, Oct 31, 2023 11:45 CET Report this content
CS MEDICA received its second-issued patent on its "Nasal Protect Gel," providing protection against pollen, bacteri... |
| 26.10.2023 | CS MEDICA: CANNASEN® is now a registered brand in Australia | CS MEDICA: CANNASEN® is now a registered brand in Australia
Thu, Oct 26, 2023 17:49 CET Report this content
CS MEDICA (”CS MEDICA” or the ”Company”) announces today that the Company has received certificates of registration for the trademar... |
| 12.10.2023 | CS MEDICA Announces Indian State’s FDA Approval for Two Cosmetic Products | CS MEDICA Announces Indian State’s FDA Approval for Two Cosmetic Products
Thu, Oct 12, 2023 14:00 CET Report this content
CS MEDICA is thrilled to announce that the Indian State’s FDA has granted official approval for two cosmetic products ... |
| 10.10.2023 | Danske Bank Backs CS MEDICA with DKK 1,2 Million Credit Line | Danske Bank Backs CS MEDICA with DKK 1,2 Million Credit Line
Tue, Oct 10, 2023 15:23 CET Report this content
Danske Bank has extended a 1,2 million DKK credit line to CS MEDICA, reaffirming its confidence in the company. This funding bolste... |
| 09.10.2023 | CS MEDICA Named Finalist in the 2023 European Lifestars Awards for Post-IPO Raise of the Year | CS MEDICA Named Finalist in the 2023 European Lifestars Awards for Post-IPO Raise of the Year
Mon, Oct 09, 2023 08:00 CET Report this content
CS MEDICA, a global MedTech company specializing in CBD and pain management, proudly announces its... |
| 18.09.2023 | CS MEDICA Initiates Registration of 6 Medical Devices in Malaysia through their Joint Venture, Rongshi MEDICA Co. Ltd. | CS MEDICA Initiates Registration of 6 Medical Devices in Malaysia through their Joint Venture, Rongshi MEDICA Co. Ltd.
Mon, Sep 18, 2023 12:07 CET Report this content
CS MEDICA ("CS MEDICA" or "the Company") is pleased t... |
| 06.09.2023 | CS MEDICA's Joint Venture with RongShi Successfully Represented at CPHI & PMEC China 2023 | CS MEDICA's Joint Venture with RongShi Successfully Represented at CPHI & PMEC China 2023
Wed, Sep 06, 2023 08:30 CET Report this content
CS MEDICA and RongShi strengthened the progress of their Joint Venture on its second Joint Fair at... |
| 30.08.2023 | CS MEDICA A/S Achieves Milestone with Patent on Nasal Night Spray | CS MEDICA A/S Achieves Milestone with Patent on Nasal Night Spray
Wed, Aug 30, 2023 12:13 CET Report this content
CS MEDICA proudly announces the issue of a patent on its “Nasal Night Spray” which provides relief to congestion during the ni... |
| 18.07.2023 | CS MEDICA A/S: Release of 2022/2023 Q3 report, for the period April – June 2023, including an invitation to a live-streamed conference call on 8nd August, at 10 AM CET. | CS MEDICA A/S: Release of 2022/2023 Q3 report, for the period April – June 2023, including an invitation to a live-streamed conference call on 8nd August, at 10 AM CET.
Tue, Jul 18, 2023 08:00 CET Report this content
CS MEDICA (”CS MEDICA” ... |
| 14.07.2023 | CS MEDICA announces that CANNORDIC India Pvt. Ltd. is Established to Expand Presence in India | CS MEDICA announces that CANNORDIC India Pvt. Ltd. is Established to Expand Presence in India
Fri, Jul 14, 2023 13:58 CET Report this content
CS MEDICA A/S (“CS MEDICA” or the “Company”), a MedTech company specializing in Cannabis and pain ... |
| 21.06.2023 | CS MEDICA A/S Signs New Own-Label Agreement on Pain Patch | CS MEDICA A/S Signs New Own-Label Agreement on Pain Patch
Wed, Jun 21, 2023 13:32 CET Report this content
CS MEDICA Signs Contract on its Popular Pain Patch for the Spanish and Portuguese Markets and Ensures an Order of 45.000 Units.
CS MED... |
| 16.06.2023 | CS MEDICA A/S Secures Trademark Approval in Canada | CS MEDICA A/S Secures Trademark Approval in Canada
Fri, Jun 16, 2023 14:37 CET Report this content
Today, CS MEDICA A/S announces it has secured trademark approval for its brand name CANNASEN® in Canada. A significant milestone for the comp... |
| 15.06.2023 | CS MEDICA A/S Secures Future Compliance with New Medical Device Regulation through Signed Contract with Notify Body | CS MEDICA A/S Secures Future Compliance with New Medical Device Regulation through Signed Contract with Notify Body
Thu, Jun 15, 2023 13:26 CET Report this content
CS MEDICA, Pioneering the Transition to MDR, Sign Contract with a Notified B... |
| 14.06.2023 | CS MEDICA A/S: Notice of Extraordinary General Meeting | CS MEDICA A/S: Notice of Extraordinary General Meeting
Wed, Jun 14, 2023 17:13 CET Report this content
The shareholders of CS MEDICA A/S ("CS MEDICA" or the "Company") are hereby notified of an Extraordinary General Meet... |
| 26.05.2023 | CS MEDICA Onboards distributors with first-year orders of DKK 5.6M and cash flow positively effect by shorter lead times | CS MEDICA Onboards distributors with first-year orders of DKK 5.6M and cash flow positively effect by shorter lead times
Fri, May 26, 2023 11:28 CET Report this content
CS MEDICA A/S will deliver 45.500 pain patches in July to customers and... |
| 17.05.2023 | CS MEDICA A/S: Publication of Q2 2022/2023 report & invitation to live-streamed conference on May 24, at 10 AM CET | CS MEDICA A/S: Publication of Q2 2022/2023 report & invitation to live-streamed conference on May 24, at 10 AM CET
Wed, May 17, 2023 08:00 CET Report this content
CS MEDICA (”CS MEDICA” or the ”Company”) hereby publishes its Q2 report f... |
| 15.05.2023 | CS MEDICA A/S’s CANNASEN® Pain Patch receives approval from Israel’s Ministry of Health and is set to debut as the first-ever OTC product with CBD in Israel. | CS MEDICA A/S’s CANNASEN® Pain Patch receives approval from Israel’s Ministry of Health and is set to debut as the first-ever OTC product with CBD in Israel.
Mon, May 15, 2023 10:53 CET Report this content
CS MEDICA's CANNASEN® Pain Patch h... |
| 09.05.2023 | CS MEDICA A/S exhibits at the leading event Vitafoods Europe with suppliers and experts from over 100 countries today | CS MEDICA A/S exhibits at the leading event Vitafoods Europe with suppliers and experts from over 100 countries today
Tue, May 09, 2023 14:30 CET Report this content
New opportunities abound at fairs. By participating in key events, CANNORD... |
| 08.05.2023 | CS MEDICA Announces Positive Results from Clinical Trial of Nasal Protect Gel for Hay Fever/Allergic Rhinitis. | CS MEDICA Announces Positive Results from Clinical Trial of Nasal Protect Gel for Hay Fever/Allergic Rhinitis.
Mon, May 08, 2023 12:14 CET Report this content
CS MEDICA's Nasal Protect Gel is a new and innovative treatment option that has d... |
| 27.04.2023 | CS MEDICA Joint Venture, RongShi MEDICA (Ordos) Co. Ltd., update | CS MEDICA Joint Venture, RongShi MEDICA (Ordos) Co. Ltd., update
Thu, Apr 27, 2023 14:00 CET Report this content
CS MEDICA and the joint venture, RongShi MEDICA (Ordos) Co. Ltd. are in progress in all areas of the business relationship and ... |
| 14.04.2023 | CS MEDICA Greenlights Establishment of CANNORDIC India Pvt. Ltd. as Part of Global Expansion Strategy | CS MEDICA Greenlights Establishment of CANNORDIC India Pvt. Ltd. as Part of Global Expansion Strategy
Fri, Apr 14, 2023 19:47 CET Report this content
CS MEDICA A/S (“CS MEDICA” or the “Company”), a MedTech company specialized in Cannabis an... |
| 14.04.2023 | CS MEDICA A/S: Statement of Extraordinary General Meeting | CS MEDICA A/S: Statement of Extraordinary General Meeting
Fri, Apr 14, 2023 16:21 CET Report this content
Today on April 14, 2023, in Copenhagen - CS MEDICA A/S (”CS MEDICA” or “The Company”) held an extraordinary general meeting (“EGM”) at... |
| 14.04.2023 | CS MEDICA A/S Announces “Proof of Concept” with Successful Clinical Trial Results of CANNASEN® Pain Patch | CS MEDICA A/S Announces “Proof of Concept” with Successful Clinical Trial Results of CANNASEN® Pain Patch
Fri, Apr 14, 2023 13:46 CET Report this content
CS MEDICA A/S (“CS MEDIA” or “The Company”), a leading MedTech company specializing in... |
| 30.03.2023 | CS MEDICA A/S: Notice of Extraordinary General Meeting | CS MEDICA A/S: Notice of Extraordinary General Meeting
Thu, Mar 30, 2023 10:18 CET Report this content
The shareholders of CS MEDICA A/S ("CS MEDICA" or the "Company") are hereby notified of an Extraordinary General Meet... |
| 30.03.2023 | Medical Device Company Approved to Prolong MDR Transition Until 31. December 2028 | Medical Device Company Approved to Prolong MDR Transition Until 31. December 2028
Thu, Mar 30, 2023 17:52 CET Report this content
CS MEDICA (“CS MEDICA or The Company”) a medical device manufacturer with leading CBD technology, has been app... |
| 26.03.2023 | CS MEDICA has entered into agreement with investor regarding directed share issue of DKK 60M at DKK 28.13 per share. | CS MEDICA has entered into agreement with investor regarding directed share issue of DKK 60M at DKK 28.13 per share.
Sun, Mar 26, 2023 19:08 CET Report this content
CS MEDICA A/S (“CS MEDICA or the company”) has entered into an agreement wi... |
| 26.03.2023 | CS MEDICA has entered a joint venture regarding production of CS-MEDICA's CANNASEN® CBD medical products in China and distribution of CANNASEN® CBD products to the Asian market. | CS MEDICA has entered a joint venture regarding production of CS-MEDICA's CANNASEN® CBD medical products in China and distribution of CANNASEN® CBD products to the Asian market.
Sun, Mar 26, 2023 19:09 CET Report this content
CS MEDICA A/S ... |
| 01.03.2023 | CS MEDICA A/S: CEO, Lone Henriksen, CFO Gitte Lund Henriksen and COO Heidi Ahlefeldt-Laurvig buys shares in the Company | CS MEDICA A/S: CEO, Lone Henriksen, CFO Gitte Lund Henriksen and COO Heidi Ahlefeldt-Laurvig buys shares in the Company
Wed, Mar 01, 2023 16:32 CET Report this content
CS MEDICA A/S (“CS MEDICA” or the “Company”) announces today that CEO, L... |
| 01.03.2023 | Correction: CS MEDICA A/S: CEO, Lone Henriksen, CFO Gitte Lund Henriksen and COO Heidi Ahlefeldt-Laurvig buys shares in the Company | Correction: CS MEDICA A/S: CEO, Lone Henriksen, CFO Gitte Lund Henriksen and COO Heidi Ahlefeldt-Laurvig buys shares in the Company
Wed, Mar 01, 2023 17:12 CET Report this content
CS MEDICA A/S (“CS MEDICA” or the “Company”) posted earliere... |
| 17.02.2023 | CS MEDICA A/S: Release of 2022/2023 Q1 report, for the period October – December 2022, including an invitation to a live-streamed conference call on 22nd February, at 10 AM CET. | CS MEDICA A/S: Release of 2022/2023 Q1 report, for the period October – December 2022, including an invitation to a live-streamed conference call on 22nd February, at 10 AM CET.
Fri, Feb 17, 2023 09:19 CET Report this content
CS MEDICA (”CS... |
| 14.02.2023 | CS MEDICA A/S: Minutes of the General Assembly | CS MEDICA A/S: Minutes of the General Assembly
Tue, Feb 14, 2023 17:52 CET Report this content
Today on February 14, 2023, in Copenhagen - CS MEDICA A/S (”CS MEDICA” or the ”Company”) held its annual general meeting (“AGM”) at which the fol... |
| 13.02.2023 | CS MEDICA engages a Financial Advisor | CS MEDICA engages a Financial Advisor
Mon, Feb 13, 2023 13:30 CET Report this content
CS MEDICA A/S (”CS MEDICA” or the ”Company”) announces today that the Company has entered into an agreement with the financial advisor Kapital Partner in ... |
| 03.02.2023 | CS MEDICA A/S issues additional information to the press release that was sent out at 16:52 CET January 18, 2022. The additional information relates to the terms of the loan. | CS MEDICA A/S issues additional information to the press release that was sent out at 16:52 CET January 18, 2022. The additional information relates to the terms of the loan.
Fri, Feb 03, 2023 11:19 CET Report this content
CS MEDICA receive... |
| 30.01.2023 | CS MEDICA A/S: Notice of Shareholders’ Annual General Meeting | CS MEDICA A/S: Notice of Shareholders’ Annual General Meeting
Mon, Jan 30, 2023 23:58 CET Report this content
The shareholders of CS MEDICA A/S (”CS MEDICA” or the ”Company”) are hereby notified of the Annual General Meeting that will be he... |
| 30.01.2023 | CS MEDICA A/S: Publication of annual report 2021/2022 | CS MEDICA A/S: Publication of annual report 2021/2022
Mon, Jan 30, 2023 23:55 CET Report this content
CS MEDICA A/S (”CS MEDICA” or the ”Company”) hereby publishes its annual report for the period October 2021 – September 2022, including th... |
| 30.01.2023 | CS MEDICA A/S: Live-streamed session following the release of the Annual Report 2021/2022 is postponed to Wednesday, 1st of February at 15:00 – 15:30 CEST | CS MEDICA A/S: Live-streamed session following the release of the Annual Report 2021/2022 is postponed to Wednesday, 1st of February at 15:00 – 15:30 CEST
Mon, Jan 30, 2023 11:52 CET Report this content
As a result of the postponement of th... |
| 27.01.2023 | Postponement of Annual General Meeting | Postponement of Annual General Meeting
Fri, Jan 27, 2023 13:50 CET Report this content
CS MEDICA postphone the Annual General meeting 2021/2022 til Tuesday the 14th of February 2023.
Due to the more extensive requireies following the adopti... |
| 20.01.2023 | CS MEDICA A/S invites to a live-streamed session of the Annual Report 2021/2022 on Janary 30th at 15:00-15:30 | CS MEDICA A/S invites to a live-streamed session of the Annual Report 2021/2022 on Janary 30th at 15:00-15:30
Fri, Jan 20, 2023 15:40 CET Report this content
CS MEDICA A/S (“CS MEDICA” or the “Company”) announces today that the company invi... |
| 18.01.2023 | CORRECTION: CS MEDICA and RongShi fail to reach a signed agreement and terminates negotiations. The negotiation with Heilongjiang FuYu ShengKun Textile Industry Co, is closed conjointly. | CORRECTION: CS MEDICA and RongShi fail to reach a signed agreement and terminates negotiations. The negotiation with Heilongjiang FuYu ShengKun Textile Industry Co, is closed conjointly.
Wed, Jan 18, 2023 16:52 CET Report this content
“Toda... |
| 18.01.2023 | CS MEDICA and RongShi fail to reach a signed agreement and terminates negotiations | CS MEDICA and RongShi fail to reach a signed agreement and terminates negotiations
Wed, Jan 18, 2023 15:01 CET Report this content
CS MEDICA A/S (“CS MEDICA” or the “Company”) terminates negotiations with Inner Mongolia Rong Shi Hi-Tech Co.... |
| 30.12.2022 | CS MEDICA A/S presents CEO Letter of December 2022 | CS MEDICA A/S presents CEO Letter of December 2022
Fri, Dec 30, 2022 13:51 CET Report this content
The year is coming to an end, and it has been an intense but successful business year, despite the negative macro events and criticism that h... |
| 29.12.2022 | CS MEDICA A/S: Update on CBD activity research and future patent | CS MEDICA A/S: Update on CBD activity research and future patent
Thu, Dec 29, 2022 15:36 CET Report this content
CS MEDICA A/S (”CS MEDICA” or the ”Company”) announces that one of two hypotheses on CBD activity in the human body has success... |
| 28.12.2022 | CS MEDICA A/S: Update on Clinical trials | CS MEDICA A/S: Update on Clinical trials
Wed, Dec 28, 2022 16:31 CET Report this content
CS MEDICA A/S (”CS MEDICA” or the ”Company”) announces that additional three clinical trials and several in-vitro tests have been initiated, and the Co... |
| 19.12.2022 | CS MEDICA A/S: The proposal to extend the transition period under the Medical Devices Regulation (EU) 2017/745 (MDR) is good news for the company. | CS MEDICA A/S: The proposal to extend the transition period under the Medical Devices Regulation (EU) 2017/745 (MDR) is good news for the company.
Mon, Dec 19, 2022 14:15 CET Report this content
CS MEDICA A/S (“CS MEDICA” or “the Company”) ... |
| 16.12.2022 | CS MEDICA Signs Deal with a New Distributor for the United Kingdom and Sweden | CS MEDICA Signs Deal with a New Distributor for the United Kingdom and Sweden
Fri, Dec 16, 2022 15:57 CET Report this content
CS MEDICA A/S ("CS MEDICA" or the" Company") announces that the company has signed a deal with... |
| 18.11.2022 | CS MEDICA A/S: Publication of interim report Q4 – Year-end-report | CS MEDICA A/S: Publication of interim report Q4 – Year-end-report
Fri, Nov 18, 2022 08:00 CET Report this content
CS MEDICA (”CS MEDICA” or the ”Company”) hereby publishes its interim report for the period October 2021 – September 2022. The... |
| 16.11.2022 | CS MEDICA A/S invites to a live-streamed session of the Q4 2021/2022 report on November 18th at 11:00 – 11:30 CEST | CS MEDICA A/S invites to a live-streamed session of the Q4 2021/2022 report on November 18th at 11:00 – 11:30 CEST
Wed, Nov 16, 2022 10:13 CET Report this content
CS MEDICA A/S (“CS MEDICA” or the “Company”) announces today that the company... |